Pediatric Frontlines

How the Collagen X Biomarker Could Change the Future of Scoliosis Care

1 h 0 min · 9. jan. 2026
episode How the Collagen X Biomarker Could Change the Future of Scoliosis Care cover

Description

how-the-collagen-x-biomarker-could-change-the-future-of-scoliosis-care [https://support.doctorpodcasting.com/media/k2/items/cache/ae624a0f25ad46f4b6200212207f50dc_S.jpg]https://support.doctorpodcasting.com/media/k2/items/cache/ae624a0f25ad46f4b6200212207f50dc_Generic.jpg Michelle Welborn, M.D., FAAOS, is the chief of spine surgery and president of the medical staff at Shriners Children’s Portland. Dr. Welborn’s research has shown that the collagen X biomarker in scoliosis patients is a key indicator of current growth and required bracing.  Learn more about Michelle C. Welborn, MD [https://www.shrinerschildrens.org/en/our-care-providers/w/michelle-c-welborn-md-57718]

Comments

0

Be the first to comment

Sign up now and become a member of the Pediatric Frontlines community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

5 episodes